Summary
HANCOUR PHARMASERVICE is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €681,051 and a net result of €82,022. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 63% of 6,630 sector peers (NACE 64, financial year 2025). The company has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Brussel-Hoofdstedelijk Gewest, Bijlagen van het Belgisch Staatsblad” (deed in Dutch)
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: “Administratieve zetels, Het bestuursorgaan kan administratieve zetels creëren, zowel in België als in het buitenland” (deed in Dutch)
Read from the deeds: 2 provisions, deed of 14-10-2026